Mechanical activation of TRP channels permits Ca2+ entry from the extracellular space, increasing cytosolic [Ca2+]. Additionally, activation of the Gq/PLC/IP3 pathway allows for IP3-mediated Ca2+ release from the ER, further increasing cytosolic [Ca2+]. This increase in cytosolic [Ca2+] activates calmodulin-dependent calcineurin phosphatase (CaM/CN) to dephosphorylate and permit nuclear translocation of NFAT and subsequent activation of the fibrotic gene program. While mitochondria can act to buffer increases in cytosolic [Ca2+] through the mitochondrial calcium uniporter complex (mtCU), the transcriptional upregulation of MICU1 alters mtCU gating, reducing mCa2+ uptake and reducing m[Ca2+]. As m[Ca2+] is an activator of numerous dehydrogenases and phosphatases within the mitochondria, this significantly reduces pyruvate oxidation and overall Krebs cycle flux. TGFβ – transforming growth factor beta; AngII – angiotensin II; ET-1 – endothelin 1; TGFBR1/2 – TGFβ receptor 1/2; TRPs – transient receptor potential channels; PLC – protein lipase C; PIP2 – phosphatidylinositol 4,5-bisphosphate; DAG – diacylglycerol; Pyr – pyruvate; PDH – pyruvate dehydrogenase; PDP – pyruvate dehydrogenase phosphatase; MICU1 – mitochondrial calcium uptake 1; NFAT – nuclear factor of activated T-cells; IDH – isocitrate dehydrogenase; ⍺KGDH - ⍺-ketoglutarate dehydrogenase; Col1a1 – collagen 1 type 1; Fn – fibronectin.